Ginkgo Bioworks Holdings (DNA) Equity Ratio (2020 - 2026)

Ginkgo Bioworks Holdings has reported Equity Ratio for 7 years, with the latest figure at 0.43 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio fell 14.3% year-over-year to 0.43; the trailing twelve-month figure through Mar 2026 stood at 0.43 (down 14.3% YoY), and the FY2025 full-year result was 0.45, down 12.62% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.43, down from 0.45 in the prior quarter.
• The five-year high for Equity Ratio was 0.79 in Q2 2022, with the low at 0.43 in Q1 2026.
• Historically, Equity Ratio has averaged 0.6 across 5 years, with a median of 0.62 in 2023.
• Annual changes were most pronounced in 2022 — Equity Ratio surged 282.47% — and 2024, when it retreated 21.86%.
• Ginkgo Bioworks Holdings' Equity Ratio stood at 0.68 in 2022, then declined by 3.65% to 0.66 in 2023, then declined by 21.09% to 0.52 in 2024, then retreated by 12.62% to 0.45 in 2025, then dropped by 5.56% to 0.43 in 2026.
• The last three Equity Ratio figures came in at 0.43 (Q1 2026), 0.45 (Q4 2025), and 0.47 (Q3 2025), per Business Quant data.